International Trade Bulletin - Volume 1, Issue 8
Client Alert | 1 min read | 06.26.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- CHINA IN THE SPOTLIGHT
- RULES OF ORIGIN: “Made in USA” Marking Update
- ANTI-DUMPING IN THE U.S.: The U.S. Department of Commerce formulates comments submitted in response to the U.S.-adverse WTO Appellate Body Report in United States – Zeroing
- FCPA: U.S. Business Optimism Tempered by Corruption in Southeast Asia
- U.S. SANCTIONS
- INTERNATIONAL IP PROTECTION: Supreme Court Decision Likely to Generate More Intellectual Property Import Protection (Section 337) Cases
- MARKET ACCESS: Korea-U.S. FTA Negotiators Set a Fast Pace in First Round of Negotiations
Contacts
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief


